Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm. [NA]
A clinical trial update for MIRRORS-FROZEN, a study comparing open versus robotic surgery for complex pelvic adnexal masses up to 8 cm, curr…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients
An exploratory study in Chinese ovarian cancer patients to examine whether the homologous recombination deficiency (HRD) score correlates wi…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating BMX-001 combined with paclitaxel in adults with advanced, recurrent, metastatic ovarian or endom…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: The Role of CircDENND4C in Epithelial Ovarian Cancer
A clinical trial by Assiut University is investigating CircDENND4C in epithelial ovarian cancer and is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating Adebrelimab combined with non-platinum chemotherapy and Fuzuloparib for recurrent platinum-resistant ovarian cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors [Phase 1, Phase 2]
A Phase 1b/2a trial evaluating ENB003 in combination with pembrolizumab for various solid tumors, including melanoma, ovarian cancer, pancre…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)
This Clinical Trial Update documents the establishment and standardization of a platform for in-depth tumor profiling (TUPRO-Gyn) in patient…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer [Phase 1]
A Phase 1 study examining the combination of pressurized intraperitoneal aerosol chemotherapy with systemic chemotherapy in women with advan…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Gynecological Cancer Associated Thrombosis (GynCAT) Study
The Gynecological Cancer Associated Thrombosis (GynCAT) study is currently recruiting to investigate cancer-associated thrombosis and venous…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Asian Multicenter Prospective Study of ctDNA Sequencing
Clinical trial update on an Asian multicenter prospective study evaluating circulating tumor DNA sequencing across multiple cancers, sponsor…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer [Phase 2]
Phase 2 trial of HS-20089 for ovarian cancer, fallopian tube cancer, primary peritoneal cancer, and endometrial cancer is currently recruiti…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer [Phase 2]
Phase 2 neoadjuvant trial of RC48 plus carboplatin for HER2-expressing advanced ovarian cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor [Phase 2]
Phase 2 study evaluating the efficacy and safety of JPI-547 in platinum-resistant advanced or relapsed ovarian cancer patients previously tr…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women [NA]
This clinical trial evaluates the efficacy and safety of FRD001 as an ultrasound contrast agent for malignant ovarian masses and is currentl…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence
A clinical trial update describing exosome-based OCS scores aimed at predicting ovarian cancer recurrence; the study is currently NOT_YET_RE…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial update on the combination of Fluzoparib and Dalpiciclib for platinum-resistant recurrent ovarian cancer, with the s…
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating the safety, tolerability, and early efficacy signals of KM1 in adults with recurrent or refractory ovarian…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK [Phase 1, Phase 2]
The ROCKIF trial is investigating re-sensitization of carboplatin-resistant ovarian cancer using a focal adhesion kinase (FAK) inhibitor, in…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating SHR-A1921 for injection in patients with platinum-resistant recurrent epithelial ovarian cancer is curre…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
A recruiting clinical trial studying 13C-glucose tracing of tumour and T cells in the ascites of patients with ovarian cancer to investigate…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling [NA]
A completed clinical trial evaluating genetic counseling augmented with an educational video or pamphlet versus traditional counseling metho…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients [Phase 2]
This entry describes a Phase 2 trial evaluating secondary cytoreduction followed by hyperthermic intraperitoneal chemotherapy for ovarian ca…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results
This clinical trial proposes a fast diffusion-weighted MRI protocol to surveil patients at high risk of ovarian cancer recurrence who are on…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating AK-104, a PD-1/CTLA-4 bispecific antibody, in combination with chemotherapy as neoadjuvant treatment for advanced…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer [Phase 2]
A Phase 2 trial investigating two standard doses of bevacizumab in combination with chemotherapy for epithelial ovarian cancer, including pl…